Drug Profile
Research programme: protein phosphatase 2A modulators - Signum Biosciences
Alternative Names: SIG 1012; SIG 1106Latest Information Update: 28 Sep 2020
Price :
$50
*
At a glance
- Originator Signum Biosciences
- Class Small molecules
- Mechanism of Action Protein phosphatase 2A modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Alzheimer's disease; Parkinson's disease; Type 2 diabetes mellitus
Most Recent Events
- 28 Sep 2020 No recent reports of development identified for research development in Alzheimer's-disease in USA (PO)
- 28 Sep 2020 No recent reports of development identified for research development in Parkinson's-disease in USA (PO)
- 13 Aug 2016 Early research in Parkinson's disease in USA (PO)